Israel Innovation Authority to invest almost $4 million in bio-convergence R&D programs

Jul 13 2020

The Israel Innovation Authority (IIA) will invest nearly $4 million in a new call for proposals in the field of bio-convergence. The IIA announced on Thursday that it is inviting researchers in academia, hospitals and commercial companies to submit requests for R&D funding to develop programs commercializing academic knowhow for medical innovation in bio-convergence, an approach that integrates biology with additional disciplines from engineering such as electronics, AI, physics, computer science, nanotechnology, material science, and advanced genetic engineering. The total budget for the project will be NIS 13.5 million (approximately $3.92 million)